The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy.
 
Missak Haigentz
Consulting or Advisory Role - Amgen; Genentech; Jazz Pharmaceuticals; Proximyl Health
 
Suresh S. Ramalingam
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; GlaxoSmithKline; Lilly/ImClone; Merck; Mirati Therapeutics; Takeda
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Gregory James Gerstner
Employment - illinois Cancer Care
Leadership - illinois Cancer Care
Stock and Other Ownership Interests - illinois Cancer Care
Research Funding - illinois Cancer Care
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Neil Morganstein
No Relationships to Disclose
 
Surya Vangala
Employment - Advaxis
Stock and Other Ownership Interests - Advaxis; Advaxis
 
Megan Parsi
Employment - Advaxis
Stock and Other Ownership Interests - Advaxis; Bristol-Myers Squibb
Consulting or Advisory Role - Oxford Global
 
Victor Kabala
Employment - Advaxis
Stock and Other Ownership Interests - Advaxis
 
Dinesh Simkhada
No Relationships to Disclose
 
Cristiane Metran
No Relationships to Disclose
 
ANDRES A. GUTIERREZ
Employment - Advaxis
Leadership - Advaxis
Stock and Other Ownership Interests - Advaxis
Travel, Accommodations, Expenses - Advaxis
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie (Inst); Advaxis (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Genentech/Roche (Inst); Lilly (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca